About: Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2000 (uk) مقالة علمية تنشرت ف 1 دجنبر 2000 (ary) article scientifique publié en 2000 (fr) im Dezember 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2000 (ast) scientific article published on 01 December 2000 (en)
publication date	wds:Q73472026-BEF4231C-725C-45B4-BEB6-6A9B30C92FBC
publication date	2000-12-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73472026-2D71507B-29A0-4286-92A6-5C8330E57C21 wds:Q73472026-4DC95AC2-27A6-41D9-B705-20B9EAD08717 wds:Q73472026-4FBB0A0A-076F-4F6C-9E1B-1D5D8EADAE9F wds:Q73472026-76E9E890-E9AA-49AB-A2C9-FE2C5F8A7A30 wds:Q73472026-8AEEB715-B690-464C-8EDC-03BFF9F6C82F wds:Q73472026-8B0D2F26-CD5A-45B7-8FCD-608077B2A7B2
cites work	Intracranial complications of paranasal sinusitis: a combined institutional review Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997) A focus on acute sinusitis in adults: changes in disease management Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group
author name string	wds:Q73472026-54B5BE6C-642F-443B-8DF0-FA2A4BAF9CB4 wds:Q73472026-8A144927-DC6E-4DD9-8746-5F67AB441A76 wds:Q73472026-992106AF-4DCE-42B1-9089-BBC7D66845CB wds:Q73472026-BB1AF847-3EA8-4001-BCAE-9D2BCEFA1E64 wds:Q73472026-BBA6B6A0-5326-4F83-B93B-B9BACD748808 wds:Q73472026-E9F8C1DB-3200-48A4-924B-4925F6697D45
author name string	E Solomon J Zhang R Palmer J J Murray G Notario D McCluskey
rdfs:label	Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (en) Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (nl)
skos:prefLabel	Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (en) Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (nl)
name	Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (en) Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (nl)
title	wds:Q73472026-98C9C7C3-F752-4A29-9FC3-3C2B0C6F4A24
title	Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis (en)
page(s)	wds:Q73472026-784AB070-A843-486B-BFDA-7592218C8CC6
page(s)	1421-1432
instance of	wds:Q73472026-DD3A624C-0E33-4A22-8A81-B2AE7B13E7E9
instance of	scholarly article
main subject	wds:Q73472026-6585BA5B-5CBB-42FB-848B-A8518F12CEEA wds:Q73472026-70DF4E63-C0BE-46EF-ADC3-234219F926AA wds:Q73472026-C615BED2-FD18-4682-89E7-B5CA90F74E3F
main subject	clarithromycin maxillary sinusitis acute maxillary sinusitis
PubMed ID	wds:Q73472026-A2535B8C-BFF7-4C50-85DE-83131E6A12A0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11192134
PubMed ID	11192134
published in	wds:Q73472026-34D61EC2-384A-432F-BD33-11446D80967F
published in	Clinical Therapeutics
issue	wds:Q73472026-FE70A8C4-3AF7-43CB-844A-20117DF7DD04
volume	wds:Q73472026-F0394D10-114F-4CF3-8E71-03EBB492CD27
issue	12
volume	22
DOI	wds:Q73472026-EB7B94F5-AD6B-4019-B350-6D0E0E170933
DOI	http://dx.doi.org/10.1016/S0149-2918(00)83041-6
DOI	10.1016/S0149-2918(00)83041-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73472026
is cites work of	An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacteri Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy Pharmacokinetics and tolerability of extended-release clarithromycin Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis Sinusitis (acute). Sinusitis (acute)
is cites work of	wds:Q35874064-21755FC0-1B0F-4984-82F1-055274AB76D8 wds:Q44999114-ADF3412F-556D-4B8F-9CD5-43D46B2FC5B9 wds:Q43805163-DF2F649C-5386-417E-90F3-B329321DC498 wds:Q33446699-E9ECD2E0-9070-42C0-9362-774D57A1E6EE wds:Q35685659-045EA4BF-7BC5-488F-8AEA-6F43243E4101 wds:Q34251698-1AB70A4A-83F7-485F-88C1-FF01BE1C3439 wds:Q34822693-4D8BD100-53C5-487C-BFC3-EA51DA302790 wds:Q39419017-B54C8F80-3807-4775-BC54-CE88D2769446 wds:Q83093998-09DA6B9A-BED3-423B-8FEA-69A19CF259FC wds:Q42694628-C4C288B3-0926-4A58-91FA-85F58028C61A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software